Is Spravato Right for You? A Spravato Therapy Guide for Rockwall, TX

If depression has not lifted despite trying multiple antidepressants and therapy, Spravato may be the next step worth considering. This nasal-spray treatment, FDA-approved specifically for treatment-resistant depression, works differently from every antidepressant that came before it. Here is what patients in Rockwall and across Rockwall County should know before scheduling a consultation.

Medically Reviewed By

Ryan H. Hashem, MD

Board-Certified Psychiatrist · Medical Director, SMHWI Rockwall

Last updated: August 25, 2026

If you have been searching for Spravato near me from Rockwall, Rowlett, Heath, Fate, Royse City, Wylie, or McLendon-Chisholm, you already know that not every depression treatment works for every person. For adults whose depression has not responded to two or more antidepressants, Spravato offers a proven, faster-acting option than anything traditional psychiatry has offered before. Here is a complete guide to what it is, how it works, and what to expect at SMHWI Rockwall.

What Is Spravato?

Spravato is the brand name for esketamine, a prescription nasal spray developed by Janssen and FDA-approved in 2019 for adults with treatment-resistant depression. In 2020, the FDA expanded its approval to include depressive symptoms in adults with major depressive disorder who have suicidal thoughts or behavior. It was the first genuinely new mechanism of action for treating depression in more than 30 years.

Unlike traditional antidepressants, which target the serotonin, norepinephrine, or dopamine systems and typically take four to six weeks to work, Spravato acts on the glutamate system through NMDA receptors. Many patients feel meaningful relief within hours to days, not weeks.

How Spravato Works

Depression is now understood to involve more than just serotonin. Research over the last two decades has shown that chronic stress and depression damage neural connections, particularly in the prefrontal cortex and hippocampus. Spravato works by blocking NMDA receptors in the brain, which triggers a cascade that helps rebuild those neural connections and restores healthier communication between mood-regulating regions.

This is why Spravato often works when SSRIs and SNRIs have not. It is not another version of what did not work. It is a fundamentally different way of treating depression.

Who Is Spravato For?

Spravato is FDA-approved for two specific populations:

• Adults with treatment-resistant depression. This typically means depression that has not adequately responded to at least two prior antidepressant medications tried at appropriate doses and for appropriate lengths of time.
• Adults with major depressive disorder and acute suicidal ideation or behavior. Spravato is one of very few treatments shown to rapidly reduce suicidal ideation in clinical trials.

Spravato is always used in combination with an oral antidepressant. It is not a replacement, but a powerful addition when the antidepressants alone have not been enough.

Off-label, some patients ask about Spravato for anxiety, PTSD, or bipolar depression. There is early research in these areas, and your psychiatrist can help you understand whether Spravato is a reasonable option based on your specific diagnosis and history.

Spravato Success Rate

Clinical trial data on Spravato is strong. In studies of adults with treatment-resistant depression, roughly 50 to 70 percent of patients experienced significant symptom improvement, and about half achieved remission. Notably, response often begins within the first few sessions, which is dramatically faster than the four to six weeks typical of oral antidepressants.

Results are strongest when Spravato is combined with ongoing psychotherapy and coordinated psychiatric care, which is how we structure Spravato treatment at SMHWI Rockwall. Spravato is not a stand-alone shot at the problem. It is one part of a larger treatment plan.

What to Expect at a Spravato Session

Every Spravato session takes place in a certified REMS-designated treatment room under direct clinical supervision. Here is what a typical session looks like:

• Check-in and vitals. A staff member checks your blood pressure and reviews any recent changes.
• Self-administration under supervision. You self-administer the nasal spray under the guidance of a nurse or clinician. It takes only a few minutes.
• The 40 to 60 minute experience. Most patients describe a floating, dreamlike, or gently detached state that starts within minutes and fades over about an hour. You are safe, monitored, and able to communicate throughout.
• Two-hour observation window. After administration, you remain in the treatment room for at least two hours so your provider can monitor blood pressure and side effects.
• Discharge with a driver. You cannot drive after a session. A family member, friend, or rideshare needs to take you home.

Spravato Treatment Schedule

Treatment typically follows a two-phase structure:

• Induction phase (weeks 1 to 4): Two sessions per week for the first four weeks.
• Maintenance phase (week 5 onward): Once weekly for four weeks, then every one to two weeks as maintenance, based on response.

Spravato Side Effects and Safety

Spravato is generally well tolerated, but because it is a controlled substance and can cause temporary dissociation, it is administered only under medical supervision. Common side effects, most of which resolve within two hours, include:

• Dissociation (feeling detached from your body, surroundings, or thoughts)
• Dizziness or vertigo
• Nausea
• Mild sedation
• Temporary increase in blood pressure
• Headache
• Numbness or tingling

Notably, Spravato does not typically cause weight gain, sexual side effects, or emotional blunting, which are common frustrations with long-term antidepressant use. Serious side effects are rare when Spravato is used as prescribed under REMS supervision.

Cost and Insurance Coverage

Without insurance, a single Spravato session typically costs between 600 and 900 dollars, and a full induction plus maintenance course involves many sessions. However, Spravato is widely covered by insurance for adults who meet the FDA-approved criteria.

Is Spravato Covered by Insurance?

Yes. Most major insurance plans cover Spravato for treatment-resistant depression, including:

• Medicare. Covered under Part B when administered in a certified facility.
• Medicaid. Covered in most states for adults meeting the treatment-resistant criteria.
• Private insurance. Blue Cross Blue Shield, Aetna, Cigna, and United Healthcare all cover Spravato under similar criteria.
• TRICARE. Covers Spravato for eligible service members and veterans, which matters given the size of the DFW veteran population.

Coverage almost always requires prior authorization and documentation of prior failed antidepressant trials. At SMHWI Rockwall, our team handles benefits verification and prior authorization before treatment begins, so you know your exact out-of-pocket cost up front.

Spravato vs. IV Ketamine

Patients often ask how Spravato compares to IV ketamine. Both are related medications, but there are meaningful differences:

• Form. Spravato is a nasal spray. IV ketamine is delivered intravenously.
• FDA approval. Spravato is FDA-approved specifically for treatment-resistant depression. IV ketamine is used off-label for depression.
• Insurance coverage. Spravato is covered by most insurance plans because it is FDA-approved. IV ketamine is typically self-pay.
• Chemistry. Spravato contains only the S-isomer (esketamine). IV ketamine contains both S- and R-isomers.
• Setting. Spravato is administered in certified REMS clinics with strict monitoring protocols. IV ketamine settings vary widely.

For most patients with treatment-resistant depression, Spravato is the more accessible option because of insurance coverage and its FDA-approved indication. But the right choice depends on your clinical picture, and we walk through both options during your consultation.

Is Spravato Right for You?

Spravato may be a strong option to discuss if you check most of these boxes:

• You are an adult with a diagnosis of major depressive disorder or treatment-resistant depression
• You have tried two or more antidepressants at appropriate doses without full relief
• You are looking for a faster-acting treatment than traditional antidepressants
• You can commit to twice-weekly sessions during the induction phase
• You can arrange transportation home after sessions (you cannot drive)
• You are willing to spend approximately two hours at the clinic for each treatment

Spravato is not typically recommended if you have uncontrolled high blood pressure, a history of aneurysm or bleeding in the brain, active substance use disorders involving dissociatives, or certain other medical conditions. Your consultation will screen carefully for eligibility.

Spravato at SMHWI Rockwall

At SMHWI in Rockwall, Spravato is delivered by board-certified psychiatrists as part of a comprehensive treatment plan. Our clinic is a certified Spravato REMS site, which means we meet the FDA's rigorous training, monitoring, and safety requirements for administering this treatment.

We serve adults across Rockwall, Rowlett, Heath, Fate, Royse City, Wylie, McLendon-Chisholm, and the wider Dallas-Fort Worth Metroplex. If Spravato is a strong fit, we build the plan around it. If a different treatment such as TMS therapy, ongoing depression care, or medication management would serve you better, we say so directly and coordinate from there.

References and Further Reading

• U.S. Food and Drug Administration (FDA). FDA Approves New Nasal Spray Medication for Treatment-Resistant Depression.
• National Institute of Mental Health (NIMH). Depression.
• Spravato (esketamine) REMS Program. spravatorems.com.